Aquestive Therapeutics Inc (AQST)
3.23
+0.03
(+0.94%)
USD |
NASDAQ |
May 15, 16:00
3.23
0.00 (0.00%)
After-Hours: 16:31
Aquestive Therapeutics Cash and Short Term Investments (Quarterly): 95.20M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 95.20M |
| December 31, 2023 | 23.87M |
| September 30, 2023 | 24.92M |
| June 30, 2023 | 22.44M |
| March 31, 2023 | 26.88M |
| December 31, 2022 | 27.27M |
| September 30, 2022 | 18.65M |
| June 30, 2022 | 17.70M |
| March 31, 2022 | 14.74M |
| December 31, 2021 | 28.02M |
| September 30, 2021 | 31.16M |
| June 30, 2021 | 34.23M |
| March 31, 2021 | 27.50M |
| Date | Value |
|---|---|
| December 31, 2020 | 31.81M |
| September 30, 2020 | 17.06M |
| June 30, 2020 | 25.42M |
| March 31, 2020 | 35.52M |
| December 31, 2019 | 49.33M |
| September 30, 2019 | 20.91M |
| June 30, 2019 | 22.16M |
| March 31, 2019 | 39.93M |
| December 31, 2018 | 60.60M |
| September 30, 2018 | 63.98M |
| June 30, 2018 | 10.64M |
| March 31, 2018 | 16.49M |
| December 31, 2017 | 17.38M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
14.74M
Minimum
Mar 2022
95.20M
Maximum
Mar 2024
29.74M
Average
26.15M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Lifecore Biomedical Inc | 19.09M |
| Harrow Inc | 75.97M |
| Akebia Therapeutics Inc | 41.96M |
| 89bio Inc | 562.29M |
| Geron Corp | 443.05M |